Several other analysts also recently commented on NVCN. HC Wainwright reaffirmed a “buy” rating and issued a $5.00 price objective on shares of Neovasc in a report on Friday, March 11th. Zacks Investment Research raised shares of Neovasc from a “sell” rating to a “hold” rating in a report on Wednesday, January 12th.
Shares of Neovasc stock opened at $0.38 on Monday. The company has a current ratio of 11.08, a quick ratio of 10.79 and a debt-to-equity ratio of 0.16. Neovasc has a 12-month low of $0.36 and a 12-month high of $1.13. The firm has a market capitalization of $25.72 million, a price-to-earnings ratio of -1.03 and a beta of 2.42. The firm’s 50 day simple moving average is $0.43 and its two-hundred day simple moving average is $0.56.
Hedge funds have recently modified their holdings of the business. UBS Group AG raised its stake in Neovasc by 564.9% during the third quarter. UBS Group AG now owns 34,701 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 29,482 shares during the period. Susquehanna International Group LLP purchased a new stake in shares of Neovasc in the 4th quarter valued at approximately $26,000. Goldman Sachs Group Inc. purchased a new stake in shares of Neovasc in the 2nd quarter valued at approximately $70,000. Citadel Advisors LLC raised its stake in shares of Neovasc by 60.5% in the 2nd quarter. Citadel Advisors LLC now owns 118,434 shares of the medical equipment provider’s stock valued at $109,000 after acquiring an additional 44,641 shares during the period. Finally, Renaissance Technologies LLC purchased a new stake in shares of Neovasc in the 4th quarter valued at approximately $67,000. 2.14% of the stock is currently owned by institutional investors.
Neovasc Company Profile (Get Rating)
Neovasc, Inc engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.
- Get a free copy of the StockNews.com research report on Neovasc (NVCN)
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
- 3 Bank Stocks That Are Ready to Handle Whatever the Fed Throws at Them
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.